High-resolution, high-magnification video of patient-specific iPSC-derived cardiomyocytes (1). This material relates to a paper that appeared in the Jun. 29, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by N. Sayed at Stanford University School of Medicine in Stanford, CA; and colleagues was titled, "Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy."
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.